Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol-Autonell I, Melchiotti R, Skowera A, Fidanis E, Dolton GM, Tungatt K, Sewell AK, Heck S, Saxena A, Beam CA, Peakman M.

J Clin Invest. 2018 Jul 16. pii: 120555. doi: 10.1172/JCI120555. [Epub ahead of print]

2.

Gender Differences in the Structure of Marital Quality.

Beam CR, Marcus K, Turkheimer E, Emery RE.

Behav Genet. 2018 May;48(3):209-223. doi: 10.1007/s10519-018-9892-4. Epub 2018 Mar 22.

PMID:
29569187
3.

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes Care. 2018 Apr;41(4):913. doi: 10.2337/dc18-er04a. Epub 2018 Feb 23. No abstract available.

4.

Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes.

Hao W, Wookwyk A, Beam C, Bahnson HT, Palmer JP, Greenbaum CJ.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4428-4434. doi: 10.1210/jc.2017-01713.

PMID:
29040630
5.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Alhadj Ali M, Liu YF, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, Heck S, Yang JHM, Tree TIM, Pujol-Autonell I, Yeo L, Baumard LR, Stenson R, Howell A, Clark A, Boult Z, Powrie J, Adams L, Wong FS, Luzio S, Dunseath G, Green K, O'Keefe A, Bayly G, Thorogood N, Andrews R, Leech N, Joseph F, Nair S, Seal S, Cheung H, Beam C, Hills R, Peakman M, Dayan CM.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf7779. doi: 10.1126/scitranslmed.aaf7779.

PMID:
28794283
6.

Interaction between Parental Education and Twin Correlations for Cognitive Ability in a Norwegian Conscript Sample.

Turkheimer E, Beam CR, Sundet JM, Tambs K.

Behav Genet. 2017 Sep;47(5):507-515. doi: 10.1007/s10519-017-9857-z. Epub 2017 Jul 25.

PMID:
28744605
7.

Examining the reach of a brief alcohol intervention service in routine practice at a level 1 trauma center.

Turner BJ, McCann BS, Dunn CW, Darnell DA, Beam CR, Kleiber B, Nelson KM, Fukunaga R.

J Subst Abuse Treat. 2017 Aug;79:29-33. doi: 10.1016/j.jsat.2017.05.011. Epub 2017 May 20.

PMID:
28673524
8.

A Twin Study on Perceived Stress, Depressive Symptoms, and Marriage.

Beam CR, Dinescu D, Emery R, Turkheimer E.

J Health Soc Behav. 2017 Mar;58(1):37-53. doi: 10.1177/0022146516688242. Epub 2017 Jan 31.

9.

Core Values of NAHN's Membership Committee.

Cueto A, Amador R, Beam C, Chick CI, Rosario-Diaz RS, Valdez S.

Hisp Health Care Int. 2017 Jun;15(2):88. doi: 10.1177/1540415317711499. No abstract available.

PMID:
28558494
10.

Turner syndrome and Duchenne muscular dystrophy.

Verma S, Goyal P, Beam C, Shah D.

Muscle Nerve. 2017 Aug;56(2):E12-E15. doi: 10.1002/mus.25618. Epub 2017 May 30. No abstract available.

PMID:
28214339
11.

Gene-environment interplay in depressive symptoms: moderation by age, sex, and physical illness.

Petkus AJ, Beam CR, Johnson W, Kaprio J, Korhonen T, McGue M, Neiderhiser JM, Pedersen NL, Reynolds CA, Gatz M; IGEMS Consortium.

Psychol Med. 2017 Jul;47(10):1836-1847. doi: 10.1017/S0033291717000290. Epub 2017 Feb 16.

12.

GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis.

Beam CA, MacCallum C, Herold KC, Wherrett DK, Palmer J, Ludvigsson J; Type 1 Diabetes TrialNet Study Group.

Diabetologia. 2017 Jan;60(1):43-49. Epub 2016 Oct 4.

13.

Genetic and environmental associations between body dissatisfaction, weight preoccupation, and binge eating: Evidence for a common factor with differential loadings across symptom type.

O'Connor SM, Beam CR, Luo X, Cohen LA, VanHuysse JL, Emery RE, Turkheimer E, Keel PK, Burt SA, Neale M, Boker S, Klump K.

Int J Eat Disord. 2017 Feb;50(2):157-161. doi: 10.1002/eat.22625. Epub 2016 Sep 16.

14.

A Comprehensive Review of Common Respiratory Infections Encountered in Urgent and Primary Care: A Reference Guide for Judicious Antibiotic Use with Complementary Therapies.

Beam C, Fuss J, Stoelting-Gettelfinger W.

J Emerg Nurs. 2016 Sep;42(5):376-86. doi: 10.1016/j.jen.2016.02.012. Epub 2016 Jul 21. Review. No abstract available.

PMID:
27452150
15.

Is marriage a buzzkill? A twin study of marital status and alcohol consumption.

Dinescu D, Turkheimer E, Beam CR, Horn EE, Duncan G, Emery RE.

J Fam Psychol. 2016 Sep;30(6):698-707. doi: 10.1037/fam0000221. Epub 2016 Jun 23.

16.

The Scarr-Rowe Interaction in Complete Seven-Year WISC Data from the Louisville Twin Study: Preliminary Report.

Turkheimer E, Beam CE, Davis DW.

Behav Genet. 2015 Nov;45(6):635-9. doi: 10.1007/s10519-015-9760-4. Epub 2015 Oct 26.

17.

Twin Differentiation of Cognitive Ability Through Phenotype to Environment Transmission: The Louisville Twin Study.

Beam CR, Turkheimer E, Dickens WT, Davis DW.

Behav Genet. 2015 Nov;45(6):622-34. doi: 10.1007/s10519-015-9756-0. Epub 2015 Oct 14.

18.

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.

Bingley PJ, Rafkin LE, Matheson D, Steck AK, Yu L, Henderson C, Beam CA, Boulware DC; TrialNet Study Group.

Diabetes Technol Ther. 2015 Dec;17(12):867-71. doi: 10.1089/dia.2015.0133. Epub 2015 Sep 16.

19.

Widowhood and the Stability of Late Life Depressive Symptomatology in the Swedish Adoption Twin Study of Aging.

Beam CR, Emery RE, Reynolds CA, Gatz M, Turkheimer E, Pedersen NL.

Behav Genet. 2016 Jan;46(1):100-13. doi: 10.1007/s10519-015-9733-7. Epub 2015 Aug 25.

20.

Statistical considerations when analyzing biomarker data.

Beam CA.

Clin Immunol. 2015 Nov;161(1):31-6. doi: 10.1016/j.clim.2015.05.019. Epub 2015 Jun 23.

PMID:
26111480
21.

State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Simons M, Alitalo K, Annex BH, Augustin HG, Beam C, Berk BC, Byzova T, Carmeliet P, Chilian W, Cooke JP, Davis GE, Eichmann A, Iruela-Arispe ML, Keshet E, Sinusas AJ, Ruhrberg C, Woo YJ, Dimmeler S; American Heart Association Council on Basic Cardiovascular Sciences and Council on Cardiovascular Surgery and Anesthesia.

Circ Res. 2015 May 22;116(11):e99-132. doi: 10.1161/RES.0000000000000054. Epub 2015 Apr 30. No abstract available.

22.

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787. Epub 2015 Mar 10.

23.

Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody.

Reilly EB, Phillips AC, Buchanan FG, Kingsbury G, Zhang Y, Meulbroek JA, Cole TB, DeVries PJ, Falls HD, Beam C, Gu J, Digiammarino EL, Palma JP, Donawho CK, Goodwin NC, Scott AM.

Mol Cancer Ther. 2015 May;14(5):1141-51. doi: 10.1158/1535-7163.MCT-14-0820. Epub 2015 Mar 2.

24.

Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective.

Bollyky JB, Xu P, Butte AJ, Wilson DM, Beam CA, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group.

Diabetes Metab Res Rev. 2015 Sep;31(6):588-94. doi: 10.1002/dmrr.2643. Epub 2015 Apr 23.

25.

β cell death and dysfunction during type 1 diabetes development in at-risk individuals.

Herold KC, Usmani-Brown S, Ghazi T, Lebastchi J, Beam CA, Bellin MD, Ledizet M, Sosenko JM, Krischer JP, Palmer JP; Type 1 Diabetes TrialNet Study Group.

J Clin Invest. 2015 Mar 2;125(3):1163-73. doi: 10.1172/JCI78142. Epub 2015 Feb 2.

26.

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.

Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2015 Feb;38(2):271-6. doi: 10.2337/dc14-1813. Epub 2014 Dec 17.

27.

ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Peterson ED, Ho PM, Barton M, Beam C, Burgess LH, Casey DE Jr, Drozda JP Jr, Fonarow GC, Goff D Jr, Grady KL, King DE, King ML, Masoudi FA, Nielsen DR, Stanko S.

J Am Coll Cardiol. 2014 Nov 18-25;64(20):2133-45. doi: 10.1016/j.jacc.2014.09.003. Epub 2014 Nov 3. No abstract available.

28.

ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Peterson ED, Ho PM, Barton M, Beam C, Burgess LH, Casey DE Jr, Drozda JP Jr, Fonarow GC, Goff D Jr, Grady KL, King DE, King ML, Masoudi FA, Nielsen DR, Stanko S.

Circulation. 2014 Nov 25;130(22):1984-94. doi: 10.1161/CIR.0000000000000139. Epub 2014 Nov 3. No abstract available.

29.

Analysis of β-cell death in type 1 diabetes by droplet digital PCR.

Usmani-Brown S, Lebastchi J, Steck AK, Beam C, Herold KC, Ledizet M.

Endocrinology. 2014 Sep;155(9):3694-8. doi: 10.1210/en.2014-1150. Epub 2014 Jul 8.

30.

Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline.

Orban T, Beam CA, Xu P, Moore K, Jiang Q, Deng J, Muller S, Gottlieb P, Spain L, Peakman M; Type 1 Diabetes TrialNet Abatacept Study Group.

Diabetes. 2014 Oct;63(10):3449-57. doi: 10.2337/db14-0047. Epub 2014 May 16.

31.

Marital Dissolution and Major Depression in Midlife: A Propensity Score Analysis.

Sbarra DA, Emery RE, Beam CR, Ocker BL.

Clin Psychol Sci. 2014 May;2(3):249-257. doi: 10.1177/2167702613498727. Epub 2013 Aug 13.

32.

Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr.

Max Andersen ML, Nielsen LB, Svensson J, Pörksen S, Hougaard P, Beam C, Greenbaum C, Becker D, Petersen JS, Hansen L, Mortensen HB.

Pediatr Diabetes. 2014 Aug;15(5):345-54. doi: 10.1111/pedi.12098. Epub 2013 Nov 25.

PMID:
24731251
33.

Recommendations for the definition of clinical responder in insulin preservation studies.

Beam CA, Gitelman SE, Palmer JP; Type 1 Diabetes TrialNet Study Group.

Diabetes. 2014 Sep;63(9):3120-7. doi: 10.2337/db14-0095. Epub 2014 Apr 10.

34.

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.

Sosenko JM, Skyler JS, Mahon J, Krischer JP, Greenbaum CJ, Rafkin LE, Beam CA, Boulware DC, Matheson D, Cuthbertson D, Herold KC, Eisenbarth G, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups.

Diabetes Care. 2014 Apr;37(4):979-84. doi: 10.2337/dc13-2359. Epub 2014 Feb 18.

35.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17.

36.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1.

37.
38.

Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.

Kroll JL, Beam C, Li S, Viscidi R, Dighero B, Cho A, Boulware D, Pescovitz M, Weinberg A; Type 1 Diabetes TrialNet Anti CD-20 Study Group.

J Clin Virol. 2013 Jun;57(2):115-9. doi: 10.1016/j.jcv.2013.01.016. Epub 2013 Feb 17.

39.

Phenotype-environment correlations in longitudinal twin models.

Beam CR, Turkheimer E.

Dev Psychopathol. 2013 Feb;25(1):7-16. doi: 10.1017/S0954579412000867.

40.

Accounting for the physical and mental health benefits of entry into marriage: a genetically informed study of selection and causation.

Horn EE, Xu Y, Beam CR, Turkheimer E, Emery RE.

J Fam Psychol. 2013 Feb;27(1):30-41. doi: 10.1037/a0029803. Epub 2012 Oct 22.

41.

Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.

Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP; DPT-1 Study Group.

Diabetes Care. 2012 Oct;35(10):1975-80. Epub 2012 Jul 11.

42.

Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth.

Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers MJ, Schatz DA, Krischer JP; TEDDY, TRIGR, Diabetes Prevention Trial–Type 1, and Type 1 Diabetes TrialNet Natural History Study Groups.

Diabetes Care. 2012 Sep;35(9):1821-5. Epub 2012 Jun 14.

43.

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.

Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM; Type 1 Diabetes TrialNet Study Group.

Diabetes. 2012 Aug;61(8):2066-73. Epub 2012 Jun 11.

44.

The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.

Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2012 Jul;35(7):1552-5. doi: 10.2337/dc12-0011. Epub 2012 Apr 30.

45.

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.

American Academy of Family Physicians; American Academy of Hospice and Palliative Medicine; American Nurses Association; American Society of Health-System Pharmacists; Heart Rhythm Society; Society of Hospital Medicine, Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Piña IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB; ACCF/AHA Task Force on Performance Measures, Peterson ED, Masoudi FA, DeLong E, Erwin JP 3rd, Fonarow GC, Goff DC Jr, Grady KL, Green LA, Heidenreich PA, Jenkins KJ, Loth A, Shahian DM.

J Am Coll Cardiol. 2012 May 15;59(20):1812-32. doi: 10.1016/j.jacc.2012.03.013. Epub 2012 Apr 23. No abstract available.

46.

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.

Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Piña IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB; American College of Cardiology Foundation; American Heart Association Task Force on Performance Measures; American Medical Association-Physician Consortium for Performance Improvement.

Circulation. 2012 May 15;125(19):2382-401. doi: 10.1161/CIR.0b013e3182507bec. Epub 2012 Apr 23. No abstract available.

47.

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.

Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; Type 1 Diabetes TrialNet Study Group.

Diabetes Care. 2012 Jun;35(6):1213-8. doi: 10.2337/dc11-2081. Epub 2012 Mar 23.

48.

The effects of ambient lighting in chest radiology reading rooms.

Pollard BJ, Samei E, Chawla AS, Beam C, Heyneman LE, Koweek LM, Martinez-Jimenez S, Washington L, Hashimoto N, McAdams HP.

J Digit Imaging. 2012 Aug;25(4):520-6. doi: 10.1007/s10278-012-9459-5.

49.

Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies.

Mahon JL, Beam CA, Marcovina SM, Boulware DC, Palmer JP, Winter WE, Skyler JS, Krischer JP; Type 1 Diabetes TrialNet Study Group.

Clin Chim Acta. 2011 Nov 20;412(23-24):2128-31. doi: 10.1016/j.cca.2011.07.019. Epub 2011 Aug 6.

50.

Development of autoantibodies in the TrialNet Natural History Study.

Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP; TrialNet Natural History Study Group.

Diabetes Care. 2011 Sep;34(9):1897-901. doi: 10.2337/dc11-0560. Epub 2011 Jul 12.

Supplemental Content

Support Center